Ndrepepa Gjin, Mehilli Julinda, Schulz Stefanie, Iijima Raisuke, Keta Dritan, Byrne Robert A, Pache Jürgen, Seyfarth Melchior, Schömig Albert, Kastrati Adnan
Deutsches Herzzentrum, Munich, Germany.
J Am Coll Cardiol. 2008 Aug 12;52(7):512-7. doi: 10.1016/j.jacc.2008.05.009.
The aim of the study was to assess the relationship between baseline and post-procedural Thrombolysis In Myocardial Infarction (TIMI) epicardial blood flow grade and mortality in patients with acute coronary syndromes (ACS) who were treated with early percutaneous coronary intervention (PCI).
The impact of baseline and post-procedural TIMI flow grade on mortality in patients with ACS has been insufficiently studied.
This prospective registry included 10,455 patients with ACS who underwent coronary angiography and PCI: 2,853 patients with ST-segment elevation acute myocardial infarction, 3,060 patients with non-ST-segment elevation acute myocardial infarction, and 4,542 patients with unstable angina. The primary outcome was 1-year mortality.
At 1 year, there were 976 deaths: 117 deaths among patients with TIMI flow grade 0 to 1, 105 deaths among patients with TIMI flow grade 2, and 754 deaths among patients with TIMI flow grade 3 (Kaplan-Meier estimates of mortality 28.3%, 18.4%, and 8.0%, respectively; odds ratio: 1.66, 95% confidence interval [CI]: 1.57 to 1.76, p < 0.001, for TIMI flow grade 0 to 1 vs. TIMI flow grade 2 and odds ratio: 2.51, 95% CI: 2.06 to 3.06, p < 0.001, for TIMI flow grade 2 vs. TIMI flow grade 3). By using the Cox proportional hazards survival model, we identified post-PCI TIMI flow grade (hazard ratio: 0.60, 95% CI: 0.52 to 0.70; p < 0.001, for 1 grade increase in TIMI flow grade) but not baseline TIMI grade (hazard ratio: 1.08, 95% CI: 0.96 to 1.22; p = 0.20, for 1 grade increase in TIMI flow grade) as an independent correlate of 1-year mortality.
In patients with ACS treated with early PCI, post-procedural TIMI flow grade but not baseline TIMI flow grade is an independent correlate of 1-year mortality.
本研究旨在评估接受早期经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征(ACS)患者的基线和术后心肌梗死溶栓(TIMI)心外膜血流分级与死亡率之间的关系。
基线和术后TIMI血流分级对ACS患者死亡率的影响尚未得到充分研究。
这项前瞻性登记研究纳入了10455例接受冠状动脉造影和PCI的ACS患者:2853例ST段抬高型急性心肌梗死患者、3060例非ST段抬高型急性心肌梗死患者和4542例不稳定型心绞痛患者。主要结局为1年死亡率。
1年时,有976例死亡:TIMI血流分级为0至1级的患者中有117例死亡,TIMI血流分级为2级的患者中有105例死亡,TIMI血流分级为3级的患者中有754例死亡(Kaplan-Meier估计的死亡率分别为28.3%、18.4%和8.0%;TIMI血流分级为0至1级与TIMI血流分级为2级相比,比值比:1.66,95%置信区间[CI]:1.57至1.76,p<0.001;TIMI血流分级为2级与TIMI血流分级为3级相比,比值比:2.51,95%CI:2.06至3.06,p<0.001)。通过使用Cox比例风险生存模型,我们确定术后TIMI血流分级(TIMI血流分级每增加1级,风险比:0.60,95%CI:0.52至0.70;p<0.001)而非基线TIMI分级(TIMI血流分级每增加1级,风险比:1.08,95%CI:0.96至1.22;p = 0.20)是1年死亡率的独立相关因素。
在接受早期PCI治疗的ACS患者中,术后TIMI血流分级而非基线TIMI血流分级是1年死亡率的独立相关因素。